2 of Wall Street’s Favorite Stocks Worth Investigating and 1 to Turn Down
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pr
1 Industrials Stock with Exciting Potential and 2 to Question
Industrials businesses quietly power the physical things we depend on, from cars and homes to e-commerce infrastructure. Still, their generally high capital requirements expose them to the ups and dow
3 Hated Stocks Skating on Thin Ice
Rock-bottom prices don't always mean rock-bottom businesses. The stocks we're examining today have all touched their 52-week lows, creating a classic investor's dilemma: bargain opportunity or value t
1 of Wall Street’s Favorite Stock to Research Further and 2 to Steer Clear Of
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because ana
G7 chair Canada speaks to Japan, EU about market stability
TOKYO/OTTAWA (Reuters) -Canada, chair of the Group of Seven advanced economies, is working with Japan and the European Union to maintain global stability in financial markets and the financial system,
Cal-Maine Stock Sinks as DOJ Egg Price Probe Outweighs Surging Sales, Profits
Shares of Cal-Maine Foods fell 5% in premarket trading Wednesday as a request for information from the U.S. Department of Justice on egg prices outweighed surging fiscal third-quarter sales and profit
The market pummeled 401(k) accounts last week. Panic selling ensued.
Savers pulled vast sums of 401(k) money from stocks and shifted to more conservative investments, in response to the tariff-induced market turmoil. But that's not necessarily a good strategy.
Indonesians rush to gold as rupiah and stocks plunge amid US tariff worries
Hundreds of Indonesians are flocking to buy gold bars, betting that the precious metal's value could shield them from tougher economic times ahead as the currency and the stock market tumble in South
Neogen (NASDAQ:NEOG) Misses Q1 Revenue Estimates, Stock Drops
Life sciences company Neogen (NASDAQ:NEOG) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 3.4% year on year to $221 million. The company’s full-year revenue guidance of